Thomas Harbo

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

Peter Van den Bergh, Pieter A. van Doorn, Robert D. M. Hadden et al. · Journal of the Peripheral Nervous System · 2021 · 461 citations · Full text

European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

Peter Van den Bergh, Pieter A. van Doorn, Robert D. M. Hadden et al. · European Journal of Neurology · 2021 · 416 citations · Full text

Maximal isokinetic and isometric muscle strength of major muscle groups related to age, body mass, height, and sex in 178 healthy subjects

Thomas Harbo, John Brincks, Henning Andersen · European Journal of Applied Physiology · 2011 · 365 citations

Isometric Muscle Strength, Muscle Function, Kinesiology +12

Regional variation of Guillain-Barré syndrome

Alex Y. Doets, Christine Verboon, Bianca van den Berg et al. · Brain · 2018 · 301 citations · Full text